Document Detail


Medical management of bleeding esophageal varices.
MedLine Citation:
PMID:  1362377     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Vasoactive drug therapy is the only therapy that can be administered immediately to patients with suspected variceal bleeding. The optimal agent is not yet available, but somatostatin or octreotide, glypressin and vasopressin and nitroglycerin are the best candidates. Somatostatin and octreotide have the best therapeutic index as they have very few side effects. They compare well to the other agents in comparative randomized trials. In addition to being used prior to sclerotherapy, vasoactive agents may show benefit when used in combination with endoscopic methods and in the immediate interval thereafter in order to prevent early re-bleeding. This remains to be tested in clinical trials.
Authors:
A K Burroughs
Related Documents :
19579627 - Selective periesophagogastric devascularization in portal hypertension: results of 56 p...
17115317 - Early results of the treatment of internal hemorrhoid disease by infrared coagulation a...
18242937 - Comparisons of side effects using air and carbon dioxide foam for endovenous chemical a...
15095847 - Ten years' follow-up of 472 patients following transjugular intrahepatic portosystemic ...
9048387 - Comparison of general and epidural anesthesia in patients undergoing primary unilateral...
8918427 - Pudendal nerve terminal motor latency influences surgical outcome in treatment of recta...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Review    
Journal Detail:
Title:  Digestive diseases (Basel, Switzerland)     Volume:  10 Suppl 1     ISSN:  0257-2753     ISO Abbreviation:  Dig Dis     Publication Date:  1992  
Date Detail:
Created Date:  1993-02-16     Completed Date:  1993-02-16     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8701186     Medline TA:  Dig Dis     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  30-7     Citation Subset:  IM    
Affiliation:
University Department of Medicine, Royal Free Hospital and School of Medicine, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Drug Therapy, Combination
Esophageal and Gastric Varices / drug therapy*
Gastrointestinal Hemorrhage / drug therapy*
Humans
Octreotide / administration & dosage,  therapeutic use
Somatostatin / administration & dosage,  therapeutic use
Vasoconstrictor Agents / therapeutic use
Chemical
Reg. No./Substance:
0/Vasoconstrictor Agents; 51110-01-1/Somatostatin; 83150-76-9/Octreotide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical pharmacology of active variceal bleeding.
Next Document:  Prevention of upper gastrointestinal bleeding from portal hypertension in cirrhosis: rationale for m...